"World's Most Complete Market Research Reports Repository"

Global Multiple Sclerosis Drugs Market by Size, Manufacturers, Countries, Type and Mode of Administration, Forecast to 2025

  • Category : Healthcare & Pharma
  • |
  • ID : 478487
  • |
  • Publishe Date : 13-Mar-2018
  • |
  • No of Pages: 114
  • |
  • Publisher : Intellectual Research Partners

The Global Multiple Sclerosis Drugs Market was valued at XX USD in 2017 and is forecast to grow at a XX% CAGR between 2017 and 2023. This report offers comprehensive coverage on global market along with, market trends, drivers, and restraints. This report included a detailed competitive scenario and product portfolio of key vendors.

Apart from being segmented geographically, the market has been segmented on the basis of type and mode of administration.

Key companies
Biogen idec
Bayer healthcare
Teva pharmaceuticals
Pfizer
merck
sanofi-aventis
novartis

Key benefit insights in this report
*This report examines market size and growth rate by 2023
*This report provides current market and future growth expectations
*Market drivers, challenges, opportunities and threats in Global Market
*Impacts of disruptive technologies and examine the changing competitive dynamics
*Market factor analysis delivers treasured information regarding the possible purchasers and suppliers and understanding the stakeholders involved
*Examine forecast period using Porter?s five forces, supply chain and value chain analysis
*Data regarding companies and business decision by having complete insights on the market and creating in-depth analysis of market segments

Target Audience for this Report:
*Healthcare service providers
*Research and consulting firms
*Healthcare insurance companies/payers
*Healthcare institutions/providers (hospitals, medical groups, physician practices, community clinics, psychiatrists, and outpatient clinics)
*Venture capitalists
*Government agencies
*Health information exchanges
*Accountable care organizations (ACOs)

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

2 DEMOGRAPHIC OVERVIEW

3 RESEARCH METHODOLOGY
3.1 INTRODUCTION
3.1.1 PRIMARY RESEARCH
3.1.2 SECONDARY RESEARCH
3.1.3 FORECASTING MODEL
3.1.4 MARKET SIZE ESTIMATION
3.2 MARKET DYNAMICS [SWOT ANALYSIS]
3.2.1 STRENGTH
3.2.2 WEAKNESS
3.2.3 OPPORTUNITY
3.2.4 THREAT

4 PREMIUM INSIGHTS
4.1 BIGGEST MARKETS
4.2 MARKET SHARE ANALYSIS
4.3 HIGH GROWTH MARKETS
4.4 HISTORICAL vs UPCOMING TRENDS

5 MARKET OVERVIEW
5.1 MARKET DRIVERS
5.2 RESTRAINTS
5.3 OPPORTUNITIES
5.4 CHALLENGES

6 MARKET FACTOR ANALYSIS
6.1 PORTER?S FIVE FORCES
6.2 VALUE CHAIN ANALYSIS
6.3 PESTEL ANALYSIS

7 GLOBAL MARKET ANALYSIS BY TYPE
7.1 INTRODUCTION
7.2 IMMUNOMODULATORS
7.3 IMMUNOSUPPRESSANT

8 GLOBAL MARKET ANALYSIS BY MODE OF ADMINISTRATION
8.1 INTRODUCTION
8.2 ORAL
8.3 INJECTABLES

9 GLOBAL MARKET ANALYSIS BY REGION
9.1 NORTH AMERICA
9.1.1 US
9.1.2 CANADA
9.1.3 REST OF NORTH AMERICA
9.2 EUROPE
9.2.1 GERMANY
9.2.2 SPAIN
9.2.3 UK
9.2.4 REST OF EUROPE
9.3 APAC
9.3.1 CHINA
9.3.2 JAPAN
9.3.3 INDIA
9.3.4 REST OF ASIA PACIFIC
9.4 SOUTH AMERICA
9.4.1 ARGENTINA
9.4.2 BRAZIL
9.4.3 REST OF SOUTH AMERICA
9.5 MIDDLE EAST & AFRICA
9.5.1 GCC
9.5.2 SAUDI ARABIA
9.5.3 SOUTH AFRICA
9.5.4 REST OF MIDDLE EAST & AFRICA

10 MARKET TRENDS & COMPETITIVE ANALYSIS

11 COMPANY PROFILES
11.1 INTRODUCTION
11.2 BIOGEN IDEC
11.3 BAYER HEALTHCARE
11.4 TEVA PHARMACEUTICALS
11.5 PFIZER
11.6 MERCK
11.7 SANOFI-AVENTIS
11.8 NOVARTIS

Content are not available

Choose License Type